Skip to content
Home
LIVE · CORPUS
Dossier

OrbiMed Capital GP VII LLC

Medium
PersonUS
The finding

Controls or directs 32 companies in the resolved graph.

/01

Key facts

Risk signal
Controls
32 companies
Risk
Medium
Jurisdiction
US

OrbiMed Capital GP VII LLC controls or directs 32 companies (US).

/02

Control & directorships

Links are shown as observed in a source registry — we do not currently hold ownership end dates, so a link here may since have ended. Each row carries its source; check it before relying on currency.

Controlled by

None in current sources.

Directorships & controlled companies
/03

Directorship network

968 other roles

Where this entity’s officers also hold (or held) positions — the wider network reached through shared people. Roles are registry records, not a claim of control.

MBX Biosciences, Inc.
Passage BIO, Inc.
Enliven Therapeutics, Inc.
Q32 Bio Inc.
Keros Therapeutics, Inc.
Terns Pharmaceuticals, Inc.
KINNATE BIOPHARMA INC.
THESEUS PHARMACEUTICALS, INC.
Galecto, Inc.
Third Harmonic Bio, Inc.
PRONAI THERAPEUTICS INC
Arcutis Biotherapeutics, Inc.
Janux Therapeutics, Inc.
Repare Therapeutics Inc.
PANDION THERAPEUTICS HOLDCO LLC
FUSION PHARMACEUTICALS INC.
SYNTHORX, INC.

Community intel

Crowd leads · unverified

Tips, corrections and leads contributed by the community on OrbiMed Capital GP VII LLC. These are unverified leads, not WhiteIntel findings — we surface them for investigators to chase, and analyse the corroborated ones into SnakeScore.

Sign in to contribute a tip and earn reputation — it's free.
Loading tips…